Encompass Health Corporation
EHC
$85.62
$0.170.20%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.25B | 1.21B | 1.19B | 1.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.25B | 1.21B | 1.19B | 1.16B |
| Cost of Revenue | 770.10M | 734.90M | 712.50M | 688.20M | 682.80M |
| Gross Profit | 545.90M | 511.90M | 494.40M | 498.90M | 477.60M |
| SG&A Expenses | 64.20M | 67.10M | 64.00M | 69.70M | 57.20M |
| Depreciation & Amortization | 70.30M | 70.10M | 67.30M | 72.60M | 63.90M |
| Other Operating Expenses | 203.90M | 184.80M | 183.70M | 172.70M | 177.90M |
| Total Operating Expenses | 1.11B | 1.06B | 1.03B | 1.00B | 981.80M |
| Operating Income | 207.50M | 189.90M | 179.40M | 183.90M | 178.60M |
| Income Before Tax | 178.40M | 164.80M | 145.00M | 151.20M | 146.20M |
| Income Tax Expenses | 38.30M | 37.20M | 30.30M | 32.80M | 31.90M |
| Earnings from Continuing Operations | 140.10M | 127.60M | 114.70M | 118.40M | 114.30M |
| Earnings from Discontinued Operations | -1.30M | -8.50M | -1.30M | -1.20M | -1.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -26.30M | -31.50M | -28.10M | -25.80M | -25.60M |
| Net Income | 112.50M | 87.60M | 85.30M | 91.40M | 87.70M |
| EBIT | 207.50M | 189.90M | 179.40M | 183.90M | 178.60M |
| EBITDA | 277.80M | 260.00M | 246.70M | 256.50M | 242.50M |
| EPS Basic | 1.12 | 0.87 | 0.85 | 0.91 | 0.88 |
| Normalized Basic EPS | 0.85 | 0.72 | 0.63 | 0.69 | 0.66 |
| EPS Diluted | 1.10 | 0.86 | 0.84 | 0.90 | 0.87 |
| Normalized Diluted EPS | 0.83 | 0.70 | 0.62 | 0.68 | 0.65 |
| Average Basic Shares Outstanding | 99.80M | 99.50M | 99.50M | 99.50M | 99.40M |
| Average Diluted Shares Outstanding | 102.20M | 101.50M | 101.40M | 101.10M | 100.90M |
| Dividend Per Share | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Payout Ratio | 14.13% | 17.01% | 17.58% | 16.30% | 17.79% |
